We argue that there are four actions Australia should take to advance equitable global access to COVID-19 vaccines: produce, donate, redistribute and fund more COVID-19 vaccines for LICs; support a broad and workable TRIPS Waiver; invest in building production capacity in LMICs; and impose conditions on public funding for R&D for COVID-19 health products and technologies to ensure know-how is shared and pricing is fair.
History
Publication Date
2022-08-01
Journal
Australian and New Zealand Journal of Public Health